BNB Plus (BNBX) Stock Price

BNB Plus Price

NASDAQ·CLOSED
0.12
​
Market closed

Revenue has compounded at 28.2% per year over the past 19 years to 2.14 M USD. BNB Plus's net margin stands at -709.5%, down from -158.3% several years earlier.

BNB Plus stock price

Access this data via the Eulerpool API

BNB Plus business model & stock analysis

Applied DNA Sciences, Inc. engages in the provision of security solutions. The company is headquartered in Stony Brook, New York and currently employs 59 full-time employees. The company went IPO on 2001-08-24. The firm is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company's platform ingredient, at the core of all its security solutions. The company provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.

Frequently asked questions about BNB Plus

6 analysts currently rate the BNB Plus stock: 0 recommend buying, 3 holding and 3 selling.

Converted at the current exchange rate, the BNB Plus share trades at 0.11 EUR (0.12 USD).

The BNB Plus share (BNBX) is listed on 4 stock exchanges, including: NASDAQ (APDN), Frankfurt (UDJP.F), München (UDJP.MU), Düsseldorf (UDJP.DU).

The revenue cannot currently be calculated for BNB Plus.

The expected profit of BNB Plus is -42.71 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of BNB Plus is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BNB Plus stock.

The P/S cannot be calculated for BNB Plus currently.

The Eulerpool Quality Score for BNB Plus is 2/10.

The ISIN of BNB Plus is US03815U6073. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of BNB Plus is A2PUTA. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of BNB Plus is BNBX. The ticker symbol is used to trade BNB Plus shares on the stock exchange.

Fair ValueTerminal
0.10 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
82,189.81 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website adnas.com
Currency
USD
Initial public offering
Aug 24, 2001
ISIN
US03815U6073
Cusip
03815U300
Sedol
BK26FG6
Market capitalization
62,124.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.03
P/S
P/Se
—
EV/EBIT
0.19
P/B Ratio
0.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-606.92 %
Last updated Oct 10, 2026, 8:50 PM

BNB Plus Peer Group

BNB Plus Ticker

DÜSSELDORF · UDJP.DUFRANKFURT · UDJP.FMUNICH · UDJP.MUNASDAQ · APDN

All fundamentals and in-depth analysis of BNB Plus

Our stock analysis for BNB Plus stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BNB Plus. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.